HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection Against Meningococcal Challenge Afforded Mice After Immunization with Typhoid-Paratyphoid Vaccine USP.

Abstract
Mice immunized with typhoid-paratyphoid vaccine USP were found to be protected when challenged with serological groups A, B, and C of Neisseria meningitidis. Mice immunized with this vaccine both 14 and 7 days prior to challenge were protected against mean lethal doses (LD(50)) of 5,220 and 1,151 of groups A and B, respectively, and in two separate experiments they were protected against 3,568 and 268 LD(50) of group C. Mice immunized four or more times on successive days prior to challenge were also protected. They demonstrated tolerance and survived a much larger LD(50) challenge than mice immunized by any other immunization schedule. Mice immunized once or twice anytime within 7 days prior to challenge were not protected and thus failed to exhibit nonspecific resistance. Serum antibody probably was responsible for the protection afforded mice immunized 14 and 7 days prior to challenge. However, this was not demonstrated conclusively.
AuthorsA R Banknieder, L F Devine, C A Faust
JournalInfection and immunity (Infect Immun) Vol. 7 Issue 3 Pg. 361-5 (Mar 1973) ISSN: 0019-9567 [Print] United States
PMID16558076 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: